Patrick Philibert

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study.

Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study.

Journal: Open forum infectious diseases

Published: January 30, 2026

Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?

Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?

Journal: PloS one

Published: November 17, 2022

A cohort analysis of sexually transmitted infections among different groups of men who have sex with men in the early era of HIV pre-exposure prophylaxis in France.

A cohort analysis of sexually transmitted infections among different groups of men who have sex with men in the early era of HIV pre-exposure prophylaxis in France.

Journal: Journal of virus eradication

Published: December 08, 2021

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 03, 2021

An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients.

An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients.

Journal: PloS one

Published: June 24, 2021

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.

Journal: The lancet. HIV

Published: September 30, 2020

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

Journal: The New England journal of medicine

Published: March 05, 2020

Highlights from HIV Glasgow, 28-31 October 2018, Glasgow, UK.

Highlights from HIV Glasgow, 28-31 October 2018, Glasgow, UK.

Journal: Journal of virus eradication

Published: February 26, 2019

Factors associated with social deprivation among older persons living with HIV.

Factors associated with social deprivation among older persons living with HIV.

Journal: AIDS care

Published: November 24, 2018

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.

Journal: Journal of virus eradication

Published: July 28, 2018

HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?

HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?

Journal: AIDS (London, England)

Published: July 11, 2017

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.

Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.

Journal: Journal of virus eradication

Published: August 03, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026